Pericaditis Market Analysis, Scope and Forecast By 2020 to 2027
Posted by shriya on June 4th, 2021
Pericaditis Market: By Type (Acute Pericarditis, Chronic Pericarditis and Recurrent Pericarditis), By Diagnosis and Treatment [Diagnosis (Electrocardiogram (ECG), Echocardiogram, Computerized Tomography (CT), and X-Ray), Treatment (Medication and Surgical Treatment)], By End User (Hospitals and Clinics, Medical Institutes, Research Organizations and Others) and By Region - Global Forecast Till 2027
According to Market Research Future (MRFR)’s analysis, the global pericarditis market is expected to touch a valuation of USD 2,741.39 Mn by the end of 2023 up from USD 1,750.38 Mn in 2017. The report also reveals that the market is predicted to thrive at a CAGR of 7.96% during the forecast period 2018 to 2023. Cardiovascular diseases are widely prevalent across the world, and the patient population is presumed to increase further over the next couple of years. A major proportion of these patients are likely to develop symptoms of pericarditis.
Global Market for Pericarditis – Segmental Analysis:
This MRFR report offers a comprehensive segmental assessment of the global pericarditis market based on type, diagnosis & treatment, and end-user. By type, the market is segmented into acute pericarditis, chronic pericarditis, and recurrent pericarditis. Among these, the acute pericarditis market is presumed to account for a major share of the market in the upcoming years.
The global pericarditis market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. Americas is the largest regional market for pericarditis and is poised to touch a valuation of USD 1,122.46 Mn towards the end of 2023. The drastic increase in the healthcare expenditure of the U.S. and Canada is contributing significantly towards the development of the pericarditis market in the region.
Global Market for Pericarditis – Competitive Dashboard:
Some of the prominent players operating in the global pericarditis market are Pfizer Inc., Bayer AG, AstraZeneca Plc., Reckitt Benckiser Group Plc, Novartis International AG, PerkinElmer, Inc., FUJIFILM Holdings Corporation, Merck & Co., Inc., Sanofi, Allergan plc., and Johnson & Johnson Services, Inc.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/pericaditis-market-7212
Market Research Future
+1 646 845 9312
Like it? Share it!
About the Authorshriya
Joined: May 18th, 2021
Articles Posted: 81
More by this author